{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:39:12Z","timestamp":1790703552296,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA72669"],"award-info":[{"award-number":["R01 CA72669"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P01 CA 065493"],"award-info":[{"award-number":["2P01 CA 065493"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research and Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ymthe.2018.04.006","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T02:39:17Z","timestamp":1523068757000},"page":"1423-1434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice"],"prefix":"10.1016","volume":"26","author":[{"given":"Christopher A.","family":"Pennell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie L.","family":"Barnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron S.","family":"McDonald-Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Panoskaltsis-Mortari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan J.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Loschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govindarajan","family":"Thangavelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan D.","family":"Storlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Refaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott N.","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie S.","family":"Kean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.04.006_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","article-title":"The principles of engineering immune cells to treat cancer","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2018.04.006_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T\u00a0cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib4","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T\u00a0cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib5","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T\u00a0cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib6","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2011-10-387969","article-title":"CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results","volume":"119","author":"Till","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib7","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T\u00a0cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib8","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T\u00a0cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T\u00a0cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12185-016-2039-6","article-title":"Biology and clinical application of CAR T\u00a0cells for B cell malignancies","volume":"104","author":"Davila","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2018.04.006_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2018.04.006_bib14","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/CCM.0000000000002053","article-title":"Cytokine release syndrome after chimeric antigen receptor T\u00a0cell therapy for acute lymphoblastic leukemia","volume":"45","author":"Fitzgerald","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","article-title":"Managing cytokine release syndrome associated with novel T\u00a0cell-engaging therapies","volume":"20","author":"Maude","year":"2014","journal-title":"Cancer J."},{"key":"10.1016\/j.ymthe.2018.04.006_bib17","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T\u00a0cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib18","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2018.04.006_bib19","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.04.006_bib20","doi-asserted-by":"crossref","first-page":"355ra116","DOI":"10.1126\/scitranslmed.aaf8621","article-title":"Immunotherapy of non-Hodgkin\u2019s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T\u00a0cells","volume":"8","author":"Turtle","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-016-0299-5","article-title":"Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T\u00a0cell therapy","volume":"9","author":"Hu","year":"2016","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib22","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","article-title":"CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in\u00a0vivo persistence and antitumor efficacy of adoptively transferred T\u00a0cells","volume":"66","author":"Kowolik","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2018.04.006_bib23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in\u00a0vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib24","first-page":"3884","article-title":"Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development","volume":"14","author":"Zhou","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1101\/gad.11.4.476","article-title":"Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus","volume":"11","author":"Nutt","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2018.04.006_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1074-7613(02)00483-1","article-title":"Complement receptors CD21\/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses","volume":"17","author":"Haas","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2018.04.006_bib27","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.4049\/jimmunol.171.8.4062","article-title":"The tetraspanin CD81 regulates the expression of CD19 during B\u00a0cell development in a postendoplasmic reticulum compartment","volume":"171","author":"Shoham","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1099\/0022-1317-82-5-1027","article-title":"The \u2018cleavage\u2019 activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring \u20182A-like\u2019 sequences","volume":"82","author":"Donnelly","year":"2001","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib29","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1172\/JCI84813","article-title":"Targeted antibody-mediated depletion of murine CD19 CAR T\u00a0cells permanently reverses B\u00a0cell aplasia","volume":"126","author":"Paszkiewicz","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2018.04.006_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4049\/jimmunol.140.3.737","article-title":"Regulation of lymphocyte homing. I. Alterations in homing receptor expression and organ-specific high endothelial venule binding of lymphocytes upon activation","volume":"140","author":"Hamann","year":"1988","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib31","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R","article-title":"Distinct migration patterns of naive and effector CD8 T\u00a0cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity","volume":"29","author":"Potsch","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T\u00a0cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2018.04.006_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/1074-7613(95)90051-9","article-title":"Cytokine-induced differentiation of\u00a0precursor mouse CD8+ T\u00a0cells into cytotoxic CD8+ T\u00a0cells secreting Th1 or Th2 cytokines","volume":"2","author":"Sad","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2018.04.006_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","article-title":"Heterogeneity in the differentiation and function of CD8+ T\u00a0cells","volume":"62","author":"Mittr\u00fccker","year":"2014","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.ymthe.2018.04.006_bib35","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/1078-0432.CCR-12-1432","article-title":"Adoptive transfer of autologous T\u00a0cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma","volume":"18","author":"Grupp","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2018.04.006_bib36","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-09-0418","article-title":"Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of costimulated autologous T\u00a0cells","volume":"15","author":"Rapoport","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2018.04.006_bib37","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pbio.0060152","article-title":"The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas","volume":"6","author":"Refaeli","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib38","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.humpath.2009.04.001","article-title":"Pathology of graft-versus-host disease in the gastrointestinal tract","volume":"40","author":"Washington","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2018.04.006_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0602-575","article-title":"Acute graft-versus-host disease does not require alloantigen expression on host epithelium","volume":"8","author":"Teshima","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib42","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.04.006_bib43","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/bioinformatics\/bti394","article-title":"MADE4: an\u00a0R\u00a0package for multivariate analysis of gene expression data","volume":"21","author":"Culhane","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2018.04.006_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.ymthe.2018.04.006_bib45","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/nar\/gkt111","article-title":"Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods","volume":"41","author":"V\u00e4remo","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.04.006_bib46","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.4049\/jimmunol.1301523","article-title":"Preclinical in\u00a0vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T\u00a0cells: identifying a window of therapeutic opportunity?","volume":"191","author":"van der Stegen","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib47","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jcyt.2017.04.001","article-title":"Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function","volume":"19","author":"Singh","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2018.04.006_bib48","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2017-08-802413","article-title":"Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights","volume":"130","author":"Obstfeld","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib49","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-\u03b3-producing lymphocytes and IL-6- and TNF-\u03b1-producing macrophages","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib50","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/eji.1830230924","article-title":"Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels","volume":"23","author":"Matthys","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib51","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood.V128.22.3358.3358","article-title":"Tocilizumab-refractory cytokine release syndrome (CRS) triggered by chimeric antigen receptor (CAR)-transduced T\u00a0cells may have distinct cytokine profiles compared to typical CRS","volume":"128","author":"Ishii","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib52","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/intimm\/5.11.1461","article-title":"Phenotypically distinct subsets of CD4+ T\u00a0cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice","volume":"5","author":"Powrie","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib53","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mt.2010.31","article-title":"Treatment of chronic lymphocytic leukemia with genetically targeted autologous T\u00a0cells: case report of an unforeseen adverse event in a phase I clinical trial","volume":"18","author":"Brentjens","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.04.006_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/neup.12235","article-title":"TMEM119 marks a subset of microglia in the human brain","volume":"36","author":"Satoh","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.ymthe.2018.04.006_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-213X-9-70","article-title":"Isolation and characterization of a novel plasma membrane protein, osteoblast induction factor (obif), associated with osteoblast differentiation","volume":"9","author":"Kanamoto","year":"2009","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.ymthe.2018.04.006_bib56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1440-169X.2012.01333.x","article-title":"OBIF, an osteoblast induction factor, plays an essential role in bone formation in association with osteoblastogenesis","volume":"54","author":"Mizuhashi","year":"2012","journal-title":"Dev. Growth Differ."},{"key":"10.1016\/j.ymthe.2018.04.006_bib57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bone.2012.04.017","article-title":"Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells","volume":"51","author":"Tanaka","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.ymthe.2018.04.006_bib58","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00223-013-9828-1","article-title":"Involvement of the osteoinductive factors, Tmem119 and BMP-2, and the ER stress response PERK-eIF2\u03b1-ATF4 pathway in the commitment of myoblastic into osteoblastic cells","volume":"94","author":"Tanaka","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ymthe.2018.04.006_bib59","doi-asserted-by":"crossref","first-page":"e0133704","DOI":"10.1371\/journal.pone.0133704","article-title":"Obif, a transmembrane protein, is required for bone mineralization and spermatogenesis in mice","volume":"10","author":"Mizuhashi","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.04.006_bib60","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T\u00a0cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib61","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2010-01-265041","article-title":"Adoptive transfer of syngeneic T\u00a0cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib62","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T\u00a0cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib63","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T\u00a0cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.04.006_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1182\/blood-2011-07-366419","article-title":"Generation of CD19-chimeric antigen receptor modified CD8+ T\u00a0cells derived from virus-specific central memory T\u00a0cells","volume":"119","author":"Terakura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2018.04.006_bib65","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/104303403322167993","article-title":"Retroviral vectors for high-level transgene expression in T\u00a0lymphocytes","volume":"14","author":"Engels","year":"2003","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618301631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618301631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:52:18Z","timestamp":1761501138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618301631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1525001618301631"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.04.006","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.05.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}